These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23131747)

  • 1. [Primary central nervous system lymphoma: a case report and evaluation of the diagnostic value of IL-10 level in the cerebrospinal fluid].
    Mishima T; Tsuboi Y; Enomoto T; Higuchi MA; Tsugawa J; Yamada T; Tanaka T; Tsugu H; Hayashi H; Nabeshima K
    Brain Nerve; 2012 Nov; 64(11):1347-51. PubMed ID: 23131747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.
    Song Y; Zhang W; Zhang L; Wu W; Zhang Y; Han X; Yang C; Zhang L; Zhou D
    Sci Rep; 2016 Dec; 6():38671. PubMed ID: 27924864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma.
    Zhang Y; Zou D; Yin J; Zhang L; Zhang X; Wang W; Zhang M; Zhou D; Zhang W
    BMC Cancer; 2021 Feb; 21(1):183. PubMed ID: 33618687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.
    De Luca A; Antinori A; Cingolani A; Larocca LM; Linzalone A; Ammassari A; Scerrati M; Roselli R; Tamburrini E; Ortona L
    Br J Haematol; 1995 Aug; 90(4):844-9. PubMed ID: 7669663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
    Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
    Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of 55-year-old female with primary central nervous system lymphoma, presenting with brain and eye lesions and long-term relapsing/remitting course].
    Sasaki T; Nakayama T; Kitamura M; Kakuta Y; Imafuku I
    Rinsho Shinkeigaku; 2015; 55(8):567-72. PubMed ID: 26156255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 10 Level in the Cerebrospinal Fluid as a Possible Biomarker for Lymphomatosis Cerebri.
    Hashiguchi S; Momoo T; Murohashi Y; Endo M; Shimamura M; Kawasaki T; Kanada S; Nozawa A; Tada M; Koyano S; Tanaka F
    Intern Med; 2015; 54(12):1547-52. PubMed ID: 26073248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
    Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
    BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
    Zhou XQ; Liu XQ; Kong JC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
    Ferreri AJM; Calimeri T; Lopedote P; Francaviglia I; Daverio R; Iacona C; Belloni C; Steffanoni S; Gulino A; Anghileri E; Diffidenti A; Finardi A; Gagliardi F; Anzalone N; Nonis A; Furlan R; De Lorenzo D; Terreni MR; Martinelli V; Sassone M; Foppoli M; Angelillo P; Guggiari E; Falini A; Mortini P; Filippi M; Tarantino V; Eoli M; Ciceri F; Doglioni C; Tripodo C; Locatelli M; Cangi MG; Ponzoni M
    Br J Haematol; 2021 May; 193(3):497-505. PubMed ID: 33620087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of primary intraocular central nervous system lymphoma with high interleukin 10 level and positive cytology in cerebrospinal fluid].
    Hideyama T; Tanaka H; Uesaka Y; Kunimoto M; Miwa A
    Rinsho Shinkeigaku; 2008 Jun; 48(6):415-8. PubMed ID: 18616153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and surgical pitfalls of an unusual primary central nervous system lymphoma.
    Günaydin A; Er U; Acuduman A; Sabuncuoğlu H; Oztürk E
    Turk Neurosurg; 2007 Apr; 17(2):129-33. PubMed ID: 17935030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
    Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
    Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
    Baraniskin A; Deckert M; Schulte-Altedorneburg G; Schlegel U; Schroers R
    Br J Haematol; 2012 Feb; 156(4):421-32. PubMed ID: 22077417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic delay in primary central nervous system lymphoma.
    Haldorsen IS; Espeland A; Larsen JL; Mella O
    Acta Oncol; 2005; 44(7):728-34. PubMed ID: 16227164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An autopsy case of primary central nervous system lymphoma with diffuse intracerebral lesion].
    Kazahaya Y; Doi A; Hamaya K
    No To Shinkei; 1992 Jan; 44(1):65-70. PubMed ID: 1562388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
    Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
    Murase S; Saio M; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Cancer Lett; 1998 Oct; 132(1-2):181-6. PubMed ID: 10397472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
    Whitcup SM; Stark-Vancs V; Wittes RE; Solomon D; Podgor MJ; Nussenblatt RB; Chan CC
    Arch Ophthalmol; 1997 Sep; 115(9):1157-60. PubMed ID: 9298057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.